HRT in 2025: What's Changed and What Hasn't

For many women, the conversation around hormone replacement therapy has been defined by fear — a fear rooted largely in a 2002 study that linked HRT to increased breast cancer risk and was widely reported without the nuance it required. The fallout was significant: millions of women stopped treatment, and a generation of physicians became reluctant to prescribe it.

In the years since, researchers have revisited that data. The picture that has emerged is meaningfully different — and more women and providers are approaching hormone care with fresh eyes.

What the Research Actually Shows

The 2002 Women's Health Initiative study involved a specific formulation of hormone therapy in a population of older, postmenopausal women. Subsequent analysis found that the risks it identified were not uniform across all women, all formulations, or all stages of menopause. For women who begin hormone therapy within ten years of menopause onset — what researchers call the "timing hypothesis" — the risk profile looks quite different.

More recent studies have reinforced the benefits of appropriately timed, appropriately dosed hormone therapy: reduced risk of osteoporosis, improved cardiovascular markers, better cognitive function, and meaningful relief from symptoms including hot flashes, sleep disruption, vaginal atrophy, and mood changes.

Bioidentical vs. Synthetic Hormones

One of the most common questions women bring to their providers is about bioidentical hormones — compounds that are structurally identical to the hormones produced by the body. FDA-approved bioidentical hormones exist and have strong evidence behind them. Compounded bioidentical hormones, often marketed as more "natural," are a different category — less standardized, less regulated, and with a more limited evidence base.

A well-informed provider will walk you through the difference and help you understand what formulation makes sense for your situation.

What a Good Hormone Consultation Looks Like

Hormone care should begin with a thorough assessment — not a prescription pad. Expect your provider to:

• Review your full symptom picture, not just the most disruptive symptoms
• Order baseline labs including estrogen, progesterone, testosterone, thyroid, and cortisol where relevant
• Discuss your personal and family medical history in detail
• Explain the range of delivery options — oral, transdermal, vaginal — and why one might suit you better than another
• Set a follow-up schedule to assess response and adjust dosing

Beyond Menopause: Perimenopause and Younger Women

Hormone care isn't only for women in menopause. Perimenopause — the transition that can begin years before the final menstrual period — often involves significant hormonal fluctuation that affects sleep, mood, weight, and cognition. Many women in their late 30s and 40s are navigating this transition without recognizing it for what it is.

A provider who understands the full hormonal arc of a woman's life — not just the endpoint of menopause — is worth seeking out.